Clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) [Phase 1]
Phase 1 trial update of belzutifan (PT2977, MK-6482) in patients with advanced solid tumors; study status is Phase 1 and not recruiting.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: 89Zr-DFO-girentuximab Expanded Access Program (EAP)
This clinical trial update indicates that the 89Zr-DFO-girentuximab Expanded Access Program for Clear Cell Renal Cell Carcinoma is available…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders [Phase 2]
A Phase 2 clinical trial at Oslo University Hospital is testing fecal microbiota transplantation from clinical responders in cancer patients…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases [Phase 2]
A Phase 2 clinical trial update describes Zanzalintinib for metastatic clear cell renal cell carcinoma with bone metastases, currently not y…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC) [Phase 2]
A Phase 2 trial evaluating belzutifan for indolent metastatic clear cell renal cell carcinoma, comparing active surveillance with treatment;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC
This clinical trial update reports on AURORAX-0087A, a study evaluating glycosaminoglycan (GAG) scores for surveillance of recurrence in non…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009) [Phase 1]
Phase 1 study evaluating Zanzalintinib (XL092) in combination with AB521, and Zanzalintinib with AB521 plus Nivolumab, in participants with …
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer [Phase 2]
A Phase 2 trial update evaluating imaging approaches for post-operative staging in kidney cancer, comparing 89Zr-DFO-GmAb PET/CT to contrast…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
Ongoing clinical study assessing a contrast-enhanced CT-based deep learning model to preoperatively predict disease-free survival in localiz…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients [Phase 1, Phase 2]
This report summarizes pharmacokinetics, biodistribution, radiation dose, and safety findings from a Phase 1/2 study of the radiopharmaceuti…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: SLM + Axitinib for Clear Cell RCC [Phase 1]
Clinical trial update reports completion of a Phase 1 study evaluating SLM in combination with axitinib for advanced/metastatic clear cell r…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy [Phase 2]
Phase 2 clinical trial evaluating immune PET imaging and proteomics to assess response to spatially fractionated or palliative radiotherapy …
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
A clinical trial update for NCT06195150 on Von Hippel-Lindau related renal cancer (Clear Cell Renal Cell Carcinoma) at IRCCS San Raffaele, c…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: 68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision [Phase 2]
A Phase 2 clinical trial evaluating 68Ga-NYM096 PET/CT for detecting clear cell renal cell carcinoma in presurgical patients with complex cy…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
A multicenter study is evaluating an 18F-labeled PET imaging agent (NY104) for renal cell carcinoma imaging, currently in recruitment.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC [Phase 1]
Phase 1 clinical trial evaluating CD70-targeted CAR-NKT cells (CGC738) for advanced clear cell renal cell carcinoma; currently not yet recru…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
A retrospective cohort study evaluating genes related to tertiary lymphoid structures as predictors of prognosis in patients with clear cell…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer
This ClinicalTrials.gov study is evaluating the use of dual-energy spectral CT to evaluate response to first-line therapies in patients with…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer [EARLY_Phase 1]
This early-phase 1 trial update reports completion of a study evaluating daratumumab in patients with muscle-invasive bladder cancer and met…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative Survival
A completed multicenter study evaluates visceral fat area as a prognostic biomarker for postoperative survival in patients with clear cell r…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Radiopharmaceutical Treatment of Advanced Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating radiopharmaceutical treatment for advanced/metastatic clear cell renal cell carcinoma; status is not yet r…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma Patients
The trial evaluated expression of HPGD and SCLO2A1 in patients with Clear Cell Renal Cell Carcinoma and is marked as completed.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Prognostic Significance of the Lung Immune Prognostic Index (LIPI) in Postoperative Clear Cell Renal Cell Carcinoma: a Multicenter Retrospective Cohort Study
A multicenter retrospective study assesses whether the Lung Immune Prognostic Index (LIPI) has prognostic value after surgical resection in …
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study [Phase 3]
Phase 3 imaging study ZIRCON-CP evaluating 89Zr-TLX250 for PET/CT in clear cell renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) [Phase 2]
Phase 2 clinical trial evaluating belzutifan in combination with cabozantinib for clear cell renal cell carcinoma; the MK-6482-003 study is …